Abstract:Vascular disrupting agents disrupt tumour vessels, blocking the nutritional and oxygen supply tumours need to thrive. This is achieved by damaging the endothelium lining of blood vessels, resulting in red blood cells (RBCs) entering the tumour parenchyma. RBCs present in the extracellular matrix are exposed to external stressors resulting in biochemical and physiological changes. The detection of these changes can be used to monitor the efficacy of cancer treatments. Spectroscopic photoacoustic (PA) imaging is an ideal candidate for probing RBCs due to their high optical absorption relative to surrounding tissue. The goal of this work is to use PA imaging to monitor the efficacy of the vascular disrupting agent 5,6‐Dimethylxanthenone‐4‐acetic acid (DMXAA) through quantitative analysis.4T1 breast cancer cells were injected subcutaneously into the left hind leg of eight BALB/c mice. After 10 days, half of the mice were treated with 15 mg/kg of DMXAA and the other half were injected with saline. All mice were imaged using the VevoLAZR X PA system before treatment, 24 and 72 hours after treatment. The imaging was done at six wavelengths and linear spectral unmixing was applied to the PA images to quantify three forms of hemoglobin (oxy, deoxy and met‐hemoglobin). After imaging, tumours were histologically processed and H&E and TUNEL staining were used to detect the tissue damage induced by the DMXAA treatment.The total hemoglobin concentration remained unchanged after treatment for the saline treated mice. For DMXAA treated mice, a 10% increase of deoxyhemoglobin concentration was detected 24 hrs after treatment and a 22.6% decrease in total hemoglobin concentration was observed by 72 hrs. A decrease in the PA spectral slope parameters was measured 24 hours after treatment. This suggests that DMXAA induces vascular damage, causing red blood cells to extravasate. Furthermore, H&E staining of the tumour showed areas of bleeding with erythrocyte deposition. These observations are further supported by the increase in TUNEL staining in DMXAA treated tumours, revealing increased cell death due to vascular disruption. This study demonstrates the capability of PA imaging to monitor tumour vessel disruption by the vascular disrupting agent DMXAA.This article is protected by copyright. All rights reserved.

Photoacoustic small-animal microscopic imaging of monitoring photodynamic therapy

Functional Imaging of Cerebrovascular Activities in Small Animals Using High-Resolution Photoacoustic Tomography.

Photoacoustic Imaging Technology for Clinical Applications

Early-Stage Imaging of Nanocarrier-Enhanced Chemotherapy Response in Living Subjects by Scalable Photoacoustic Microscopy

Progress of Photoacoustic Imaging Combined with Targeted Photoacoustic Contrast Agents in Tumor Molecular Imaging.

In Vivo Quantitative Vasculature Segmentation and Assessment for Photodynamic Therapy Process Monitoring Using Photoacoustic Microscopy

Photoacoustic imaging biomarkers for monitoring biophysical changes during nanobubble-mediated radiation treatment

In Vivo Small Animal Imaging for Early Assessment of Therapeutic Efficacy of Photodynamic Therapy for Prostate Cancer.

Nanoparticle-enhanced photoacoustic diagnosis and photothermal treatment of small-animal early-stage liver cancer

Single-Impulse Panoramic Photoacoustic Computed Tomography of Small-Animal Whole-Body Dynamics at High Spatiotemporal Resolution

A portable photoacoustic microscopy and ultrasound system for rectal cancer imaging

Mini review of photoacoustic clinical imaging: a noninvasive tool for disease diagnosis and treatment evaluation

Photoacoustic tomography and sensing in biomedicine.

Three-Dimensional Deep-Tissue Functional and Molecular Imaging by Integrated Photoacoustic, Ultrasound, and Angiographic Tomography (PAUSAT)

Quantitative Analysis on in Vivo Tumor‐microvascular Images from Optical‐resolution Photoacoustic Microscopy

Photoacoustic microscopy: a potential new tool for evaluation of angiogenesis inhibitor.

In vivo Online label-free monitoring of heterogenous oxygen utilization during phototherapy with real-time ultrasound guided photoacoustic imaging

Use of photoacoustic imaging for monitoring vascular disrupting cancer treatments

Non-invasive Monitoring of Ultrasound-Stimulated Microbubble Radiation Enhancement Using Photoacoustic Imaging

Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer

Super‐Low‐Dose Functional and Molecular Photoacoustic Microscopy